Altria is a top choice for building passive income with stable cash flows, despite potential tech stock valuation slowdowns. Learn more about MO stock here.

U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first that could curb smoking and hit tobacco industry earnings. The U.S. Food and Drug Administration (FDA),

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a look at where Altria Group, Inc. (NYSE:MO) stands against the other high-yield dividend stocks.

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.

Altria just rewarded its shareholders again with a dividend. This high-yield stock has boosted its payout annually for more than 50 years.

Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability

The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application

Even if the effort goes ahead under Trump, tobacco companies like Reynolds American and Altria are almost certain ... and said Wednesday that reducing nicotine would help nearly 13 million current ...

Shares of Altria Group, Inc. (NYSE:MO – Get Free Report) have received an average recommendation of “Hold” from the eight research firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation,